每日一文(Jan 2002)

Jan 31,2002 Why Is p53 Acetylated?

Recent studies suggest that acetylation of the p53 tumor suppressor protein is not important for its DNA binding activity, as was previously thought. We discuss here a number of theories as to how this modification may serve to regulate the protein’s functions.

Jan 30,2002 Organogenesis—Heart and Blood Formation from the Zebrafish Point of View

The zebrafish is a powerful model system that is poised to contribute to our basic understanding of vertebrate organogenesis. This review develops the theme of modules and illustrates how zebrafish have been particularly useful for understanding heart and blood formation.

Jan 29,2002 Blocking Caspase-Activated Apoptosis Improves Contractility in Failing Myocardium

This study investigated the role of caspase activation in cardiac contractility and sarcomere organization in the development of CHF.

Jan 28,2002 Atherosclerosis as an autoimmune disease: an update

Here,we summarize the data on which we have built our immunological hypothesis of atherogenesis. This concept is based on the observation that almost all humans have cellular and humoral immune reactions against microbial heat-shock protein 60 (HSP60).

Jan 27,2002 Mucosa-targeted DNA vaccination

Targeting DNA to mucosal sites through a covalently linked viral adhesin induces strong mucosal cytotoxic T-cell responses. Pathways involving two distinct cell types – dendritic cells and M cells – could mediate DNA sampling at mucosal surfaces.

Jan 26,2002 Part three in the book of genes

Working out the draft sequence of the human genome was a landmark achievement. But there’s lots more to be done before the finished product is available. The complete sequence of chromosome 20 sets us on the way.

Jan 25,2002 Data, data, everywhere…

To take advantage of this, many branches of biology may need to be transformed — moving from bench sciences dominated by competing research groups into collaborative enterprises. This would see entire research communities organized around databases and associated computational tools. In such fields, these online resources could eventually replace the conventional scientific paper as the predominant form of communication.

Jan 24,2002 The price of tumour suppression?

The p53 protein works to suppress cancer, so one might think that bumping up the levels of this protein would be a good idea. But this isn’t so — mice with too much p53 age prematurely. p53 SIR2

Jan 23,2002 Tumor necrosis factor-α converting enzyme

Tumor necrosis factor-α converting enzyme (TACE/ADAM17/CD156q) is a member of the ‘A Disintegrin And Metalloprotease’, or ADAM, family.

Jan 22,2002 Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants

To evaluate function, we developed a method for systematic construction of double mutants, termed synthetic genetic array (SGA) analysis, in which a query mutation is crossed to an array of;4700 deletion mutants.

Jan 21,2002 Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy

We designed a βA globin gene variant that prevents HbS polymerization and introduced it into a lentiviral vector we optimized for transfer to hematopoietic stem cells and gene expression in the adult red blood cell lineage.

Jan 20,2002 PPARγ and Atherosclerosis: Effects on Cell Growth and Movement

TZD activation of PPAR may protect against atherosclerosis both by normalizing proatherogenic metabolic abnormalities of the insulin resistance/diabetes milieu and through an inhibition of vascular cell growth and movement.

Jan 19,2002 Immune Mechanisms in Atherosclerosis

Experimental research has identified several candidate antigens, and there are encouraging data suggesting that immune modulation as well as immunization can reduce the progression of the disease. This review provides an overview of our current understanding of the role of immune mechanisms in atherosclerosis.

Jan 18,2002 Role of Id Family Proteins in Growth Control

Id proteins (inhibitors of DNA binding/differentiation) are negative regulators of basic helix-loop-helix (bHLH) type transcription factors, which promote the differentiation of various cell types.

Jan 17,2002 Roads to Polyploidy: The Megakaryocyte Example

Here, we review the mechanisms that lead to this cell cycle and to polyploidy in megakaryocytes, while also comparing them to those described for other systems in which high ploidy is achieved.

Jan 16,2002 p63

The p 63 gene, a member of the p53 gene family, is expressed into at least six protein isoforms which are divided into two groups, those containing the transcription activation domain (TA isoforms) and those that do not (ΔN isoforms).

Jan 15,2002 Human Gene Marker/Therapy Clinical Protocols recommended

The most comprehensive Gene Therapy Protocols,including 472 clinical protocols in America and 38 international ones.

Jan 14,2002 Rethinking genetic strategies to study complex diseases

Understanding the genetic basis of complex diseases is turning out to be difficult, prompting a widespread (re-)evaluation of the relevant issues.

Jan 13,2002 Taking a functional genomics approach in molecular medicine

The elucidation of genetic components of human diseases at the molecular level provides crucial information for developing future causal therapeutic intervention.Here I will discuss the relevance of genome research for disease gene identification and the future progress in molecular medicine.

Jan 12,2002 Using genetic variation to study human disease

The study of single nucleotide polymorphisms (SNPs), the most common type of variant, is likely to contribute substantially to deciphering genetic determinants of common and rare diseases.

Jan 11,2002 Molecular epidemiology, biomarkers and cancer prevention

Here we discuss examples of recent susceptibility studies involving genes, such as those involved in carcinogen metabolism, DNA repair, cell cycle and immune status, that hold the promise of increasing our understanding of cancer etiology and possible prevention strategies.

Jan 10,2002 Mouse-based phenogenomics for modelling human disease

Development of appropriate tools for assessing clinical phenotypes in mice is a crucial component of these endeavours, as is the establishment of the infrastructure for archiving and distribution of the growing mutant resource to the community.

Jan 09,2002 Genetics and genomics in infectious disease susceptibility

Comparative sequence analysis of pathogen strains and functional genomics studies are now underway, hopefully providing new insight into infectious disease susceptibility.

Jan 08,2002 Evidence of oxidative damage in Alzheimer’s disease brain: central role for amyloid β-peptide

Here,we summarize current research on phospholipid peroxidation, as well as protein and DNA oxidation, in AD brain, and discuss the potential role of Aβ in this oxidative stress.

Jan 07,2002 DNA fusion vaccines against B-cell tumors

DNA fusion vaccines containing immuno-enhancing sequences can augment and direct immune attack on a range of target antigens. Gene-based fusion vaccines offer ease of manipulation and flexible design to activate effective attack on cancer.

Jan 06,2002 Chromosomal translocations in sarcomas: prospects for therapy

In the past two decades, cytogenetic and molecular genetic investigations have revealed that sarcomas are frequently characterized by specific chromosomal translocations, often involving genes encoding transcription factors.

Jan 05,2002 Animal models for respiratory chain disease

In this review,we present an overview of the field and discuss in depth a few examples of animal models reproducing pathology of human disease with primary and secondary respiratory chain involvement.

Jan 04,2002 Tumor environment: a potent driving force in colorectal cancer?

Recent studies found evidence of dynamic changes in cellular adhesion and β-catenin localization occurring during invasion, metastasis and expansion of well-differentiated colorectal cancers. It is proposed that such changes might be driven by the local tumor environment, which, if validated,would necessitate a revision of the current linear tumor progression model.

Jan 03,2002 Visualizing the growth of Alzheimer’s Aβamyloid-like fibrils

Seeded growth of Aβ1–40 amyloid-like fibrils on a mica surface imaged by atomic force microscopy (AFM).

Jan 02,2002 The molecular basis and potential role of survivin in cancer diagnosis and therapy

Survivin is a recently described molecule that has been implicated in both the control of cell proliferation and the regulation of cell lifespan, and is overexpressed in most human cancers.The exploitation of the survivin signaling pathway might provide important predictive and prognostic clues in cancer diagnosis, and offer new therapeutic alternatives for cancer treatment.

Jan 01,2002 Vascular Smooth Muscle Growth:Autocrine Growth Mechanisms
Others:
Jan 2001